Dare Bioscience Inc (DARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 8,441 | 7,582 | 7,126 | 4,254 | 3,861 |
| Operating Income | -8,441 | -7,582 | -7,126 | -4,254 | -3,861 |
| Other Income | -1 | -1 | 2 | 2 | -6 |
| Pre-tax Income | -8,442 | -7,583 | -7,124 | -4,252 | -3,867 |
| Net Income Continuous | -8,442 | -7,583 | -7,124 | -4,252 | -3,867 |
| Net Income | $-8,442 | $-7,583 | $-7,124 | $-4,252 | $-3,867 |
| EPS Basic Total Ops | -2.64 | -2.88 | -3.24 | -2.16 | -2.52 |
| EPS Basic Continuous Ops | -2.70 | -2.88 | -3.20 | -2.14 | -2.40 |
| EPS Diluted Total Ops | -2.64 | -2.88 | -3.24 | -2.16 | -2.52 |
| EPS Diluted Continuous Ops | -2.70 | -2.88 | -3.20 | -2.14 | -2.40 |
| EBITDA(a) | $-8,434 | $-7,569 | $-7,114 | $-4,242 | $-3,853 |